Thomas F. Baumert

Thomas F. Baumert, MD is Professor of Medicine, head of the Inserm Research Institute
for Viral and Liver Diseases (Inserm U1110), director of the Laboratory of Excellence HEPSYS
at the University of Strasbourg and Chair of Hepatology at the Center for Digestive Disease
and Hepatology at the Strasbourg University Hospitals. He received his MD from the University of Heidelberg, Germany. Following his doctoral thesis at the German Cancer Research Center (DKFZ) in Heidelberg and his internship in Internal Medicine at the Ludwig Maximilians University in Munich, he was a fellow at Harvard Medical School, Massachusetts General Hospital, and the Liver Diseases Branch at the National Institutes of Health, Bethesda, USA. He subsequently joined the Department of Medicine at the University Hospital in Freiburg, Germany to become a board-certified internist and gastroenterologist, associate professor and to establish his laboratory focussing on the molecular pathogenesis of viral hepatitis and liver disease. He then relocated to the University of Strasbourg in France as full Professor of Medicine to create and head a new Inserm research unit and establish a highly recognized program in translational hepatology. Furthermore, he
spent an academic year as research scholar the BROAD Institute of MIT and Harvard,
Cambridge, USA and the Massachusetts General Hospital, Harvard Medical School, Boston.

His research focuses on the modelling and discovery of the cell circuits underlying liver
disease and cancer. The understanding of the molecular mechanisms of liver disease biology enabled his laboratory to uncover novel strategies for prevention and treatment of chronic liver disease and hepatocellular carcinoma. He has received many awards including the Hans Popper Young Investigator Award, the Chair of Excellence and Laboratory of Excellence Awards of the French National Research Agency, the Infectious Disease Award of the German Infectious Disease Society, the Prix Galien France and Prix Galien International and most recently the Mémain-Pelletier Award of the French Academy of Science. He has received four European Research Council (ERC) awards for the discovery and development of novel approaches to prevent and treat chronic liver disease. He has published more than 300 scientific articles including N. Engl. J. Med., Lancet, Cell, Nature, Nature Medicine, Nature Biotechnology, Cell Host & Microbe, PNAS, J. Clin. Invest. and J. Exp. Med. as a senior author and is an inventor on 15 patents and patent applications.

Thomas Baumert is Associate Editor of the Journal of Hepatology and serves as a member of the editorial board of several journals in the field of Gastroenterology, Hepatology, Virology and Infectious Diseases. He is a member of the US, European, French and German Liver Societies and elected member of the American Association of Physicians (AAP). Furthermore, he is the founder of Alentis Therapeutics – a Swiss/French biotech company developing novel therapeutics for fibrotic diseases and cancer.